Search

Your search keyword '"Lawson, Jeffrey H."' showing total 16 results
Start Over Author "Lawson, Jeffrey H." Publisher sage publications
16 results on '"Lawson, Jeffrey H."'

1. Hemodialysis Reliable Outflow (HeRO) graft creation in upper extremities abandoned due to stent obstruction via recanalization and HeRO outflow component insertion across stent interstices

Author

Cline, Brendan C, primary, Zuchowski, Adam, additional, Gage, Shawn M, additional, Martin, Jonathan G, additional, Ronald, James, additional, Southerland, Kevin W, additional, Lawson, Jeffrey H, additional, Dillavou, Ellen D, additional, and Kim, Charles Y, additional

Published
2021
Full Text
View/download PDF

2. Development of a Bioartificial Vascular Pancreas

Author

Han, Edward X, primary, Wang, Juan, additional, Kural, Mehmet, additional, Jiang, Bo, additional, Leiby, Katherine L, additional, Chowdhury, Nazar, additional, Tellides, George, additional, Kibbey, Richard G, additional, Lawson, Jeffrey H, additional, and Niklason, Laura E, additional

Published
2021
Full Text
View/download PDF

6. A Multi-center, Dose-escalation Study of Human type I Pancreatic Elastase (PRT-201) Administered after Arteriovenous Fistula Creation

Author

Peden, Eric K., primary, Leeser, David B., additional, Dixon, Bradley S., additional, El-Khatib, Mahmoud T., additional, Roy-Chaudhury, Prabir, additional, Lawson, Jeffrey H., additional, Menard, Matthew T., additional, Dember, Laura M., additional, Glickman, Marc H., additional, Gustafson, Pamela N., additional, Blair, Andrew T., additional, Magill, Marianne, additional, Franano, F. Nicholas, additional, and Burke, Steven K., additional

Published
2012
Full Text
View/download PDF

10. Design of the Dialysis Access Consortium (DAC) clopidogrel prevention of early AV fistula thrombosis trial

Author

Dember, Laura M, primary, Kaufman, James S, additional, Beck, Gerald J, additional, Dixon, Bradley S, additional, Gassman, Jennifer J, additional, Greene, Tom, additional, Himmelfarb, Jonathan, additional, Hunsicker, Lawrence G, additional, Kusek, John W, additional, Lawson, Jeffrey H, additional, Middleton, John P, additional, Radeva, Milena, additional, Schwab, Steve J, additional, Whiting, James F, additional, and Feldman, Harold I, additional

Published
2005
Full Text
View/download PDF

11. Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial

Author

Dixon, Bradley S, primary, Beck, Gerald J, additional, Dember, Laura M, additional, Depner, Thomas A, additional, Gassman, Jennifer J, additional, Greene, Tom, additional, Himmelfar, Jonathan, additional, Hunsicker, Lawrence G, additional, Kaufman, James S, additional, Lawson, Jeffrey H, additional, Meyers, Catherine M, additional, Middleton, John P, additional, Radeva, Milena, additional, Schwab, Steve J, additional, Whiting, James F, additional, and Feldman, Harold I, additional

Published
2005
Full Text
View/download PDF

13. Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI).

Author

Dolmatch BL, Gurley JC, Baskin KM, Nikolic B, Lawson JH, Shenoy S, Saad TF, Davidson I, Baerlocher MO, Cohen EI, Dariushnia SR, Faintuch S, d'Othee BJ, Kinney TB, Midia M, and Clifton J

Subjects
Consensus, Constriction, Pathologic, Electronic Health Records standards, Humans, Phlebography standards, Predictive Value of Tests, Radiography, Interventional methods, Risk Factors, Treatment Outcome, Vascular Diseases diagnostic imaging, Vascular Diseases etiology, Vascular Diseases physiopathology, Vascular Patency, Radiography, Interventional standards, Research Design standards, Terminology as Topic, Thorax blood supply, Vascular Diseases therapy, Veins diagnostic imaging, Veins physiopathology
Published
2019
Full Text
View/download PDF

14. Operative and perioperative management of infected arteriovenous grafts.

Author

Benrashid E, Youngwirth LM, Mureebe L, and Lawson JH

Subjects
Anti-Bacterial Agents therapeutic use, Arteriovenous Shunt, Surgical instrumentation, Blood Vessel Prosthesis Implantation instrumentation, Humans, Predictive Value of Tests, Prosthesis-Related Infections diagnosis, Prosthesis-Related Infections microbiology, Reoperation, Risk Factors, Treatment Outcome, Arteriovenous Shunt, Surgical adverse effects, Blood Vessel Prosthesis adverse effects, Blood Vessel Prosthesis Implantation adverse effects, Debridement adverse effects, Device Removal adverse effects, Prosthesis-Related Infections surgery, Renal Dialysis
Abstract

Vascular graft infections are a particularly troublesome complication for dialysis patients, many of whom are in an already immunocompromised state. The objective of this review is to detail the risk factors, etiology, diagnosis, perioperative and operative management of vascular graft infections.

Published
2017
Full Text
View/download PDF

15. A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation.

Author

Peden EK, Leeser DB, Dixon BS, El-Khatib MT, Roy-Chaudhury P, Lawson JH, Menard MT, Dember LM, Glickman MH, Gustafson PN, Blair AT, Magill M, Franano FN, and Burke SK

Subjects
Adult, Aged, Analysis of Variance, Double-Blind Method, Drug Administration Schedule, Female, Graft Occlusion, Vascular etiology, Graft Occlusion, Vascular physiopathology, Humans, Male, Middle Aged, Pancreatic Elastase, Proportional Hazards Models, Prospective Studies, Risk Factors, Thrombosis etiology, Thrombosis physiopathology, Time Factors, Treatment Outcome, United States, Vascular Patency drug effects, Arteriovenous Shunt, Surgical adverse effects, Carrier Proteins administration & dosage, Graft Occlusion, Vascular prevention & control, Renal Dialysis, Thrombosis prevention & control, Upper Extremity blood supply
Abstract

Purpose: To explore the safety and efficacy of PRT-201., Methods: Randomized, double-blind, placebo-controlled, single-dose escalation study of PRT-201 (0.0033 to 9 mg) applied after arteriovenous fistula (AVF) creation. Participants were followed for one year. The primary outcome measure was safety. Efficacy measures were the proportion with intra-operative increases in AVF outflow vein diameter or blood flow ≥25% (primary), changes in outflow vein diameter and blood flow, AVF maturation and lumen stenosis by ultrasound criteria and AVF patency., Results: The adverse events in the PRT-201 group (n=45) were similar to those in the placebo group (n=21). There were no differences in the proportion with ≥25% increase in vein diameter or blood flow, successful maturation or lumen stenosis. There was no statistically significant difference in primary patency between the dose groups (placebo n=21, Low Dose n=16, Medium Dose n=17 and High Dose n=12). In a subgroup analysis that excluded three participants with early surgical failures, the hazard ratio (HR) for primary patency loss of Low Dose compared with placebo was 0.38 (95% CI 0.10-1.41, P=0.15). In a Cox model, Low Dose (HR 0.27, 95% CI 0.04-0.79, P=0.09), white race (HR 0.17, 95% CI 0.03-0.79, P=0.02), and age <65 years (HR 0.25, CI 0.05-1.15, P=0.08) were associated (P<0.10) with a decreased risk of primary patency loss., Conclusions: PRT-201 was not different from placebo for safety or efficacy measures. There was a suggestion for improved AVF primary patency with Low Dose PRT-201 that is now being studied in a larger clinical trial.

Published
2013
Full Text
View/download PDF

16. Anticoagulation strategies for venous thromboembolism.

Author

Peterson D, Harward S, and Lawson JH

Subjects
History, 18th Century, History, Ancient, History, Medieval, Humans, Incidence, Paintings, Time Factors, Treatment Outcome, Venous Thromboembolism blood, Venous Thromboembolism diagnosis, Venous Thromboembolism history, Venous Thromboembolism mortality, Venous Thromboembolism physiopathology, Anticoagulants therapeutic use, Blood Coagulation drug effects, Venous Thromboembolism drug therapy
Abstract

Venous thromboembolism (VTE) continues to be a major source of morbidity and mortality in the United States with an estimated incidence of greater than 600 000 clinically evident cases each year. It results in more than 200 000 deaths per year and is thought to be the number one cause of preventable in-hospital deaths. This review presents the history, pathophysiology, diagnostic considerations, and treatment options for VTE.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results